Evidence map›Paper›PMID 39847571›Full record

ReviewPLoS neglected tropical diseases2025

Leptospirosis, melioidosis, and rickettsioses in the vicious circle of neglect.

Tshokey Tshokey, Ablert I Ko, Bart J Currie, Claudia Munoz-Zanzi, Cyrille Goarant, Daniel H Paris, David A B Dance, Direk Limmathurotsakul, Emma Birnie, Eric Bertherat and 11 more

Abstract readReview
In one paragraph

Review in PLoS neglected tropical diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Review
  3. Laboratory diagnosis of melioidosis.PLoS neglected tropical diseases · 2025
    Review
  4. Article
  5. Observational
  6. Article
  7. A severe case of sepsis and pneumonia caused byOne health (Amsterdam, Netherlands) · 2025
    Article
  8. Design and set-up of the leptospirosis registryFrontiers in public health · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Tshokey TshokeyAustralian Rickettsial Reference Laboratory, University Hospital Geelong, Geelong, Australia.ORCID 0000-0002-5122-1482
Ablert I KoDepartment of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, Connecticut, United States of America.
Bart J CurrieMenzies School of Health Research, Charles Darwin University and Royal Darwin Hospital, Darwin, Australia.
Claudia Munoz-ZanziDivision of Environmental Health Sciences, School of Public Health, University of Minnesota, Minneapolis, Minnesota, United States of America.
Cyrille GoarantThe Pacific Community, Public Health Division, Noumea, New Caledonia.
Daniel H ParisDepartment of Medicine, Swiss Tropical and Public Health Institute, Allschwil, Switzerland.
David A B DanceLao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit. Microbiology Laboratory, Mahosot Hospital, Vientiane, Lao People's Democratic Republic.
Direk LimmathurotsakulMahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand and Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
Emma BirnieCenter for Infection and Molecular Medicine, Amsterdam UMC location University of Amsterdam, Amsterdam, the Netherlands.
Eric BertheratGroupe d'Intervention en Santé Publique, Marseille, France.
Gyanendra GongalWorld Health Emergency Programme, WHO Regional Office for South-East Asia, New Delhi, India.
Jackie BenschopTāwharau Ora, School of Veterinary Science, Massey University, Palmerston North, New Zealand.
Jelmer SavelkoelCenter for Infection and Molecular Medicine, Amsterdam UMC location University of Amsterdam, Amsterdam, the Netherlands.
John StenosAustralian Rickettsial Reference Laboratory, University Hospital Geelong, Geelong, Australia.
Kartika SaraswatiSaw Swee Hock School of Public Health, National University of Singapore, Singapore, Republic of Singapore.
Matthew T RobinsonLao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit. Microbiology Laboratory, Mahosot Hospital, Vientiane, Lao People's Democratic Republic.
Nicholas P J DayMahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand and Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
Stephen R GravesAustralian Rickettsial Reference Laboratory, University Hospital Geelong, Geelong, Australia.
Steven R BelmainNatural Resources Institute, University of Greenwich, London, United Kingdom.
Stuart D BlacksellMahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand and Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
Willem J WiersingaCenter for Infection and Molecular Medicine, Amsterdam UMC location University of Amsterdam, Amsterdam, the Netherlands.

Funding

World Health Organization 001
6 · The paper itself

Abstract

The global priorities in the field of infectious diseases are constantly changing. While emerging viral infections have regularly dominated public health attention, which has only intensified after the COVID-19 pandemic, numerous bacterial diseases have previously caused, and continue to cause, significant morbidity and mortality-deserving equal attention. Three potentially life-threatening endemic bacterial diseases (leptospirosis, melioidosis, and rickettsioses) are a huge public health concern especially in low- and middle-income countries. Despite their continued threat, these diseases do not receive proportionate attention from global health organizations and are not even included on the WHO list of neglected tropical diseases (NTDs). This, in turn, has led to a vicious circle of neglect with continued, yet conceivably preventable, hospitalizations and deaths each year especially in the vulnerable population. This is a call from a group of multi-institutional experts on the urgent need to directly address the circle of neglect and raise support in terms of funding, research, surveillance, diagnostics, and therapeutics to alleviate the burden of these 3 diseases.

Indexed as

LeptospirosisMelioidosisNeglected DiseasesRickettsia InfectionsCOVID-19Global HealthHumans

Identifiers

PMID39847571
PMCPMC11756766

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.